Endocrinology & Metabolic Syndrome
Open Access
ISSN: 2161-1017
+44 1478 350008
ISSN: 2161-1017
+44 1478 350008
Nancy Dunne
Bitterroot Natural Medicine Clinic, USA
Posters-Accepted Abstracts: Endocrinol Metab Syndr
Polycystic ovary syndrome (PCOS) is a condition that includes hyper-androgenic oligo or anovulation. In addition to fertility concerns, women with PCOS have substantial risk for developing metabolic syndrome and possibly endometrial cancer. Global incidence of PCOS ranges between 4% and 20% of women. Young women with PCOS suffer significant distress related to infertility as well as clinical signs of hyperandrogenism, including severe acne, thinning scalp hair and excess facial and body hair. Obesity among women with PCOS parallels rates of the general population; however the hyper-androgen aspect promotes excess visceral fat in these women. Apparently lean women with PCOS have visceral fat in excess of what is found in women who do not evidence hyperandrogenism or insulin resistance. Primary treatment of PCOS should therefore address the associated metabolic sequelae, in addition to the patient�s presenting complaint. The majority of women with PCOS present initially with concerns related to alterations in reproductive function and or cosmetic appearance. Naturopathic therapies that focus on adjusting whole family nutrition as well as each individual�s exercise and stress management strategies, to correct and maintain metabolic health, are first line prevention and treatment for PCOS. Naturopathic treatment is inherently individualized. This investigation looked for treatment elements that were common to patients who experienced desired outcomes. Applying naturopathic therapies that enhance reproductive function as well as general health has broad personal and social benefits. This study provides preliminary data on naturopathic interventions that successfully address fundamental aspects of the endocrine and metabolic conditions that accompany PCOS.
Email: nan@drnandunne.com